Skip to content

Effect of electrical brain stimulation therapy in patients with Parkinsons disease

Effect of High-definition transcranial alternating current stimulation therapy on motor symptoms in patients with Parkinsons disease - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080596
Enrollment
50
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Real transcranial alternating current stimulation (Real tACS): Real tACS Protocol: single session of real closed-loop transcranial alternating current stimulation (tACS) intervention (2

Sponsors

Suriya Prakash Muthukrishnan
Lead Sponsor
Prashant Tayade
Collaborator
Ratna Sharma
Collaborator
Simran Kaur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of idiopathic Parkinsons disease with Hoehn and Yahr Stages II to IV while on medication, 2. MDS UPDRS III motor improvement of less than or equal to 30 per cent while on medication compared to while off medication, 3. Patients on stabilized medication.

Exclusion criteria

Exclusion criteria: 1. Dopamine dysregulation syndrome, 2. Other neurological diseases such as major depression, dementia, attention deficit disorder, psychosis, or essential tremor, 3. History of epilepsy, traumatic brain injury or brain surgery, 4. Patients on psychoactive or narcoleptic medications, 5. Patients enrolled for another drug, device, biologic, or intervention trial currently or within the preceding 90 days, 6. Patients who are pregnant, breastfeeding, or planning for pregnancy during the study duration, 7. Patients with metal implants.

Design outcomes

Primary

MeasureTime frame
The main outcome which will be used to determine the effects of the intervention is Movement Disorder Society Unified Parkinsons disease rating scale part III, a reliable and valid metric for objectively evaluating motor symptoms in Parkinsons disease.Timepoint: Motor symptoms in Parkinsons disease will be objectively assessed using Part III of the Movement Disorder Society Unified Parkinsons Disease Rating Scale, MDS UPDRS III at two specific time points. 1. Baseline, 30 minutes before the intervention, 2. Post intervention, 30 minutes after the intervention.

Secondary

MeasureTime frame
Freezing of gait QuestionnaireTimepoint: Outcome measures will be recorded before and after the intervention on the same day;Timed up and go testTimepoint: Outcome measures will be recorded before and after the intervention on the same day.;Word memory taskTimepoint: Outcome measures will be recorded before and after the intervention on the same day.;Digit span forward taskTimepoint: Outcome measures will be recorded before and after the intervention on the same day.

Countries

India

Contacts

Public ContactSuriya Prakash Muthukrishnan

All India Institute of Medical Sciences, Delhi

akshayvanja7@gmail.com9773232797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026